Clarivate Identifies Fifteen Potential Blockbuster Drugs in… Leave a comment

Report highlights personalized medicines ensuring greater efficacy for rare diseases and previously untreatable conditions Promising therapeutic developments for HIV, Parkinson’s disease, Crohn’s disease, alopecia, multiple myeloma and breast cancer on horizon London, U.K., January 10, 2023: Clarivate Plc (NYSE:CLVT), a global leader in providing trusted information and insights to accelerate the pace of innovation, today announced the […]

Source